{
  "id": "b2a6c4ef804fcd9a",
  "title": "BridgeBio Nears 52 - Week High On Strong Dwarfism Trial Data , Plans FDA Filing In 2026 - BridgeBio Pharma ( NASDAQ : BBIO ) ",
  "description": "20260212T181500Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/markets/large-cap/26/02/50587029/bridgebio-nears-52-week-high-on-strong-dwarfism-trial-data-plans-fda-filing-in-2026",
  "published_at": "20260212T181500Z",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/markets/large-cap/26/02/50587029/bridgebio-nears-52-week-high-on-strong-dwarfism-trial-data-plans-fda-filing-in-2026",
    "url_mobile": "",
    "title": "BridgeBio Nears 52 - Week High On Strong Dwarfism Trial Data , Plans FDA Filing In 2026 - BridgeBio Pharma ( NASDAQ : BBIO ) ",
    "seendate": "20260212T181500Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2026/02/12/Woman-in-lab.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}